Literature DB >> 6391068

Glial fibrillary acidic protein (GFAP) in oligodendroglial tumors: gliofibrillary oligodendroglioma and transitional oligoastrocytoma as subtypes of oligodendroglioma.

M J Herpers, H Budka.   

Abstract

Immuno-reactivity to glial fibrillary acidic protein (GFAP) is mainly regarded as a sign of astroglial histogenesis and/or differentiation. The presence of astrocytes in oligodendrogliomas is a well known phenomenon; in addition, GFAP-positive neoplastic oligodendrocytes have also been described but have not yet been studied systematically. Using an anti-GFAP serum in the peroxidase-antiperoxidase antiperoxidase (PAP) technique, 50 oligodendrogliomas and 16 mixed oligodendrocytomas were investigated; they had been diagnosed by routine histological stains. In half of all oligodendrogliomas, and only in a few (12%) of the mixed oligoastrocytomas, GFAP-positive oligodendrocytes were found in some areas of the classical honey-comb texture with a prominent vascular stroma. The term 'gliofibrillary oligodendrocyte' (gfoc) is proposed for these immuno-reactive cells. The existence of a tumour cell combining morphological characteristics of oligodendroglia with GFAP production in its cytoplasm may be considered analogous to transient GFAP expression by myelin-forming glia during normal development (Choi and Kim 1984), thus suggesting the return to a foetal behaviour by some neoplastic oligodendrocytes. Three tumours of the present series consisted largely of gfocs and, therefore, may be termed gliofibrillary oligodendrogliomas. In about 32% of all oligodendrogliomas, but only once in the mixed tumour group, a gradual morphological transition from gfocs to gemistocytic astrocytes was observed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6391068     DOI: 10.1007/BF00690392

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  18 in total

1.  AN ELECTRON MICROSCOPIC STUDY OF DYSTROPHIC AXONS IN THE GRACILE AND CUNEATE NUCLEI OF VITAMIN E-DEFICIENT RATS.

Authors:  P LAMPERT; J M BLUMBERG; A PENTSCHEW
Journal:  J Neuropathol Exp Neurol       Date:  1964-01       Impact factor: 3.685

2.  The role of glial fibrillary acidic protein in the diagnosis of central nervous system tumors.

Authors:  J H Deck; L F Eng; J Bigbee; S M Woodcock
Journal:  Acta Neuropathol       Date:  1978-06-30       Impact factor: 17.088

3.  Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors.

Authors:  L F Eng; L J Rubinstein
Journal:  J Histochem Cytochem       Date:  1978-07       Impact factor: 2.479

4.  Glial filaments in the myelin sheath after vinblastine implantation.

Authors:  A Hirano; H M Zimmerman
Journal:  J Neuropathol Exp Neurol       Date:  1971-01       Impact factor: 3.685

5.  A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium.

Authors:  M C Raff; R H Miller; M Noble
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

6.  Immunocytochemical study of the glial fibrillary acidic protein in human neoplasms of the central nervous system.

Authors:  N A Tascos; J Parr; N K Gonatas
Journal:  Hum Pathol       Date:  1982-05       Impact factor: 3.466

7.  Expression of glial fibrillary acidic protein in immature oligodendroglia.

Authors:  B H Choi; R C Kim
Journal:  Science       Date:  1984-01-27       Impact factor: 47.728

8.  Glial fibrillary acidic protein in human gliomas.

Authors:  J D van der Meulen; H J Houthoff; E J Ebels
Journal:  Neuropathol Appl Neurobiol       Date:  1978 May-Jun       Impact factor: 8.090

9.  Production of glial fibrillary acidic protein (GFAP) by neoplastic cells: adaptation to the microenvironment.

Authors:  M J Herpers; H Budka; D McCormick
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

10.  Quantitation of glial fibrillary acidic protein in human brain tumours.

Authors:  S Rasmussen; E Bock; K Warecka; G Althage
Journal:  Br J Cancer       Date:  1980-01       Impact factor: 7.640

View more
  27 in total

1.  Diagnosis of malignant glioma: role of neuropathology.

Authors:  Daniel J Brat; Richard A Prayson; Timothy C Ryken; Jeffrey J Olson
Journal:  J Neurooncol       Date:  2008-08-20       Impact factor: 4.130

2.  Proteomic identification of glutamine synthetase as a differential marker for oligodendrogliomas and astrocytomas.

Authors:  Zhengping Zhuang; Meng Qi; Jie Li; Hiroaki Okamoto; David S Xu; Rajiv R Iyer; Jie Lu; Chunzhang Yang; Robert J Weil; Alexander Vortmeyer; Russell R Lonser
Journal:  J Neurosurg       Date:  2011-06-17       Impact factor: 5.115

3.  Oligoastrocytomas: a clinicopathological study of 52 cases.

Authors:  H G Krouwer; S G van Duinen; W Kamphorst; P van der Valk; A Algra
Journal:  J Neurooncol       Date:  1997-07       Impact factor: 4.130

4.  Prenatal metyrapone treatment modulates neonatal cerebrovascular structure, function, and vulnerability to mild hypoxic-ischemic injury.

Authors:  P Naomi Franco; Lara M Durrant; Desirelys Carreon; Elizabeth Haddad; Adam Vergara; Catherine Cascavita; Andre Obenaus; William J Pearce
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-02       Impact factor: 3.619

Review 5.  Oligodendrogliomas: clinicopathological correlations.

Authors:  J M Kros
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

6.  Uniform lineage of oligodendrogliomas.

Authors:  S M de la Monte
Journal:  Am J Pathol       Date:  1989-09       Impact factor: 4.307

7.  GFAP expression in the subcutaneous tumors of immature glial cell line (HITS glioma) derived from ENU-induced rat glioma.

Authors:  Y Ikeno; I Shimokawa; Y Higami; T Ikeda
Journal:  J Neurooncol       Date:  1993-09       Impact factor: 4.130

8.  Oligodendroglioma: an analysis of 42 cases.

Authors:  I M Wilkinson; J R Anderson; A E Holmes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-03       Impact factor: 10.154

9.  Ultrastructural characteristics of glial fibrillary acidic protein expression in epoxy resin-embedded human brain tumors.

Authors:  B Bozóky; T Krenács; Z Rázga; A Erdös
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Non-glial specificities of immunocytochemistry for the glial fibrillary acidic protein (GFAP). Triple expression of GFAP, vimentin and cytokeratins in papillary meningioma and metastasizing renal carcinoma.

Authors:  H Budka
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.